BioRegenx, Inc. (BRGX)
OTCMKTS · Delayed Price · Currency is USD
0.0076
0.00 (0.00%)
Jul 17, 2026, 9:30 AM EST
BioRegenx Revenue
BioRegenx had revenue of $426.18K in the quarter ending March 31, 2026, a decrease of -17.27%. This brings the company's revenue in the last twelve months to $1.77M, down -23.43% year-over-year. In the year 2025, BioRegenx had annual revenue of $1.85M, down -20.75%.
Revenue (ttm)
1.77M
Revenue Growth
-23.43%
P/S Ratio
4.18
Revenue / Employee
294.26K
Employees
6
Market Cap
7.38M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.85M | -485.59K | -20.75% |
| Dec 31, 2024 | 2.34M | -1.07M | -31.40% |
| Dec 31, 2023 | 3.41M | 3.37M | 7,991.78% |
| Dec 31, 2022 | 42.16K | -3.95M | -98.94% |
| Dec 31, 2021 | 3.99M | -3.80M | -48.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pharma-Bio Serv | 9.11M |
| CareView Communications | 8.97M |
| DATATRAK International | 6.50M |
| CompuMed | 1.69M |
| Mitesco | 21.70K |
BioRegenx News
- 1 year ago - BioRegenx, Inc. Engages Sichenzia Ross Ference Carmel LLP for Legal Representation in Connection with Planned Uplisting to National Stock Exchange - Accesswire